JS GLOBAL LIFE (01691) announced its interim results for the six months ended June 30, 2025, reporting revenue of US$774 million, representing a year-over-year increase of 4.19%. The company recorded a shareholder loss of US$59.242 million, compared to a shareholder profit of US$21.797 million in the same period last year, marking a shift from profit to loss. Basic loss per share was 1.7 US cents.